A Brain-Targeted Nanozyme System for Alleviating Poststroke Neuroinflammation via Synergistic Antioxidant and Anti-inflammatory Mechanisms
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c13505 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Boyang Wei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Center, Department of Cerebrovascular Surgery, The National Key Clinical Specialty, The Engineering Technology Research Center of Educat…. Hauptthemen laut MEDLINE: Antioxidants, Anti-Inflammatory Agents, Neuroinflammatory Diseases, Stroke. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Health Commission of the People's Republic of China.
Abstract (Originalsprache)
Ischemic stroke (IS) is severely aggravated by oxidative stress and neuroinflammation, while the blood−brain barrier (BBB) poses a major obstacle to effective therapy. Herein, we developed a brain-targeted nanozyme system (TLNP@Pt/Fe3O4) by encapsulating Pt/Fe3O4 nanozymes into T7 peptide-modified lipid nanoparticles. Pt/Fe3O4 exhibited stable multienzymatic activities (SOD/CAT/POD-like) and favorable biocompatibility. Mediated by T7 peptide targeting, the nanoparticle efficiently penetrated the BBB, enhanced cellular uptake in microglia, and reduced nontarget organ accumulation. In vitro experiments demonstrated that TLNP@Pt/Fe3O4 effectively scavenged reactive oxygen species (ROS), reversed proinflammatory microglial polarization, and inhibited neuronal apoptosis. In a mouse model of transient middle cerebral artery occlusion (tMCAO), TLNP@Pt/Fe3O4 alleviated cerebral infarct and edema, while improving neurological and spatial cognitive functions. Mechanistically, scRNA-Seq showed that the nanozyme synergistically regulated redox homeostasis and the inflammatory microenvironment through the PI3K/AKT signaling pathways. Integrating targeted delivery, multienzymatic catalysis, and multitarget regulation, TLNP@Pt/Fe3O4 provides a promising and translatable therapeutic strategy for IS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurosurgery Center, Department of Cerebrovascular Surgery, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Di…
ORCID-Profile: Xifeng Li, Chuanzhi Duan
Förderung
- National Health Commission of the People's Republic of China
Zitieren
APA
Wei, B., Wu, Y., Zhou, J., Li, L., Jin, L., Liu, W., Jin, F., Li, R., Guo, S., Yang, Z., Su, S., Li, X., & Duan, C. (2026). A Brain-Targeted Nanozyme System for Alleviating Poststroke Neuroinflammation via Synergistic Antioxidant and Anti-inflammatory Mechanisms. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c13505
Vancouver
Wei B, Wu Y, Zhou J, Li L, Jin L, Liu W, et al. A Brain-Targeted Nanozyme System for Alleviating Poststroke Neuroinflammation via Synergistic Antioxidant and Anti-inflammatory Mechanisms. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c13505
BibTeX
@article{Wei2026,
author = {Wei, Boyang and Wu, Yu and Zhou, Jiaming and Li, Longxiang and Jin, Lei and Liu, Wenchao and Jin, Fa and Li, Ran and Guo, Shenquan and Yang, Zeyu and Su, Shixing and Li, Xifeng and Duan, Chuanzhi},
title = {A Brain-Targeted Nanozyme System for Alleviating Poststroke Neuroinflammation via Synergistic Antioxidant and Anti-inflammatory Mechanisms},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c13505}
}
EUVIMED